Birgit C. Schultes

EVP, Chief Scientific Officer, Intellia Therapeutics.

Companies

Intellia TherapeuticsEVP, Chief Scientific Officer Jan 23, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Intellia Therapeutics NTLA137,733 shares²$1.6M at $11.48Mar 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 1, 2026Granted 39,200 shares of Intellia Therapeutics²
Jan 5, 2026Sold 8,508 shares at $9.21 of Intellia Therapeutics³
Oct 1, 2025Sold 31 shares at $17.38 of Intellia Therapeutics⁴
Mar 1, 2025Granted 37,600 shares of Intellia Therapeutics⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIntellia Therapeutics, EVP, Chief Scientific Officer
2
SEC EDGARIntellia Therapeutics shares after the filing of Mar 1, 2026
3
SEC EDGARForm 4 filed Jan 7, 2026
4
SEC EDGARForm 4 filed Oct 3, 2025
5
SEC EDGARForm 4 filed Mar 4, 2025